Medicine & Life Sciences
South Africa
100%
HIV
44%
AIDS Vaccines
44%
Vaccines
31%
HIV-1
21%
HIV Infections
19%
Placebos
14%
Immunization
13%
Candidemia
13%
Vaccination
12%
Acinetobacter baumannii
12%
Multidrug-Resistant Tuberculosis
12%
Risk-Taking
11%
Hepatitis B virus
9%
ceftaroline fosamil
9%
Namibia
9%
Tertiary Care Centers
8%
Genes
8%
Safety
8%
Pregnancy
8%
Pregnant Women
8%
Polymerase Chain Reaction
7%
Serogroup
7%
Mycoplasma genitalium
7%
Papillomavirus Vaccines
7%
Fluconazole
7%
Laboratory Infection
7%
Incidence
7%
Foams and Jellies Vaginal Creams
7%
Viral Load
7%
Genotype
7%
Mycoplasma Infections
7%
Fungemia
7%
Infections
7%
Sentinel Surveillance
7%
Tenofovir
7%
Disease Outbreaks
7%
Uganda
6%
vpu Genes
6%
Sexual Health
6%
Kenya
6%
Edible Plants
6%
Immunization Programs
6%
Urethritis
6%
Candida parapsilosis
6%
Whole Genome Sequencing
6%
Coinfection
6%
Candida
6%
Sexually Transmitted Diseases
6%
Multiple Drug Resistance
6%
Eswatini
6%
Population
6%
Streptococcus
6%
Streptococcus agalactiae
6%
Salmonella enterica
6%
Trans-Activators
6%
Phase II Clinical Trials
6%
Genetic Variation
6%
Molecular Epidemiology
5%
Ceftriaxone
5%
Adenoviridae
5%
Child
5%
Reproductive Health Services
5%
Clinical Trials
5%
Highly Active Antiretroviral Therapy
5%
Mutation
5%
Delayed Diagnosis
5%
Randomized Controlled Trials
5%
Microsatellite Repeats
5%
Health
5%
Sexual and Gender Minorities
5%
Occupational Groups
5%
Sexual Behavior
5%
Tuberculosis
5%
Neutropenia
5%
Neutralizing Antibodies
5%